Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
Finegold, S. M., Howard, R. A., & Vera, L. S. (1974). Effect of diet on human intestinal fecal flora: comparison of Japanese and American diets. Am. J. Clin. Nutr, 27, 1456–1469.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human faeces and clinical sources
DNA G+C(%): 44
|
Opt. T: 37℃
Lower T(℃): 30(+)
High T(℃): 45(neg)
NaCl >6%: 6.5(neg)
Bile reaction(%): 20(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amp-sulb: S(MIC50): 0.5, MIC90: 1, RNG: (0.06–1)
|
cefoxitin: Var(MIC50): 4, MIC90: 128, RNG: (0.06–128)
|
|
|
levofloxacin: Var(MIC50): 2, MIC90: 8, RNG: (0.25–>16)
moxifloxacin: Var(MIC50): 1, MIC90: 4, RNG: (0.25–8)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
vancomycin: S(MIC50): 1, MIC90: 2, RNG: (0.25–32)
|
|
metronidazole: S(MIC50): 0.25, MIC90: 1, RNG: (0.06–1)
|
clindamycin: Var(MIC50): 2, MIC90: 16, RNG: (0.06–>32)
|